Prof Michael Gantier's lab @Hudson_Research studies the immunology of nucleic acids (such as mRNA therapeutics)
Australia
Joined May 2021
- Tweets90
- Following131
- Followers129
- Likes315
Gantier Lab retweeted
Researchers led by Drs. Michael Gantier (@GantierLab), Toshiyuki Shimizu, and Ben Corry (@CorryLab) show that modified #RNA from our own cells naturally blocks TLR7 and TLR8, preventing harmful immune activation.
📖: go.nature.com/4azVWjp
🔊: bit.ly/40muGA2
Gantier Lab retweeted
Recognition of RNA fragments by TLR7 and TLR8 helps to initiate the innate immune response.
This work redefines TLR7 and TLR8 sensing by introducing 2′-OMe guanosine as a natural immune checkpoint for their activation. @NatImmunol
🔗 go.nature.com/4azVWjp
Gantier Lab retweeted
How does your immune system tell pathogenic RNA from your own, even though they’re made of the same stuff? Our latest paper with
@GantierLab
shows some self RNA act as an off switch preventing autoimmunity in the absence of pathogens. 🧬🔬⭐ nature.com/articles/s41590-0…
Gantier Lab retweeted
IsomiR stoichiometry changes as disease biomarkers. dlvr.it/TLDYyK #MTNA
Gantier Lab retweeted
We are thrilled to announce the official launch of the #RNAte Platform at @Hudson_Research, delivering huge advances in the development of #mRNA-based therapies. 🥳💪🏽
Read more about this revolutionary platform: bit.ly/3SEEl23
@VicGovAu @VicGov_DJSIR
Gantier Lab retweeted
We recently welcomed Deputy Premier & Minister for Medical Research, The Hon @BenCarrollMP to Hudson Institute! 🙌
Minister Carroll went behind the scenes with some of our researchers, including our CEO & Director Prof Elizabeth Hartland, to learn more about our research.🔬
ALT Deputy Premier & Minister for Medical Research, The Hon Ben Carroll and Hudson Institute CEO & Director Professor Elizabeth Hartland
ALT Deputy Premier & Minister for Medical Research, The Hon Ben Carroll speaks with researchers at Hudson Institute
Gantier Lab retweeted
Thrilled to be joining longtime friends and colleagues @CiiiD_Hudson including those I could find on twitter @ProfHartland @FerreroMicro @Tate_Lab @GantierLab @pjhpauljh @Forster_Lab @PhilBardin
Gantier Lab retweeted
Exciting data to build our research program on thromboinflammation! So proud of this first research paper! Thanks to the many students and collaborators who contribute to this story! life-science-alliance.org/co…
Gantier Lab retweeted
Our latest work, out today in @PLOSBiology suggests that not only do mammalian cells absorb bacteriophages, but they appear to use them as a resource to enhance growth!
journals.plos.org/plosbiolog…
This work was led by @marion_bichet and out on World Phage Week! #WorldPhageWeek
Gantier Lab retweeted
(2/2) Talks from: @ShaliniChelliah (@elaine_sanij lab, @SVIResearch), @QiZhang85 (@MonashBDI), @eric_kusnadi (@PeterMacCC), Steve Rockman (@CSL) and Cameron Stuart (@CSIRO).
@traude_beilharz
@GantierLab
@ClarksysCorner
@nadia_davidson
@jacki_hf
@EMBLAustralia
Gantier Lab retweeted
RNA Victoria meeting: Dec 5, 2023, at @MonashUni.
Program & FREE registration: rnavic.com
🙏RT! #RNAvic
Gantier Lab retweeted
Noxopharm’s Dr Olivier Laczka and Associate Professor Michael Gantier from @Hudson_Research are currently showcasing the team’s latest breakthroughs at the Oligonucleotide Therapeutics Society Annual Meeting in Barcelona.
#biotech #Innovation #mRNA
Gantier Lab retweeted
Great to be on Proactive again talking about our work with the great team @Hudson_Research.
$NOX Noxopharm talks partnership with Hudson Institute of Medical Research tinyurl.com/ysvwncvu @noxopharm $NOXOF #NOX #NOXOF #ASX #ASXNews
Gantier Lab retweeted
New study alert: Researchers have discovered that a cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients. More here: centenary.org.au/news/cancer… @HansbroResearch @mattdjohansen @UTS_Science @GantierLab @Hudson_Research
Gantier Lab retweeted
A/Prof Michael Gantier, PhD student Tomalika Ullah & the team have established that idronoxil, which was originally designed to treat cancers, could reduce the #Inflammation that occurs in response to COVID-19.🦠
Read more in Nature Communications, or: bit.ly/3LoQaFh
ALT "Uncontrolled inflammation is one of the major life-threatening aspects of COVID-19." A/Prof Michael Gantier
Gantier Lab retweeted
@Mykalt45 What else does TBK1/IKKe not do?
We are delighted to share our work on the importance of TBK1 in SARSCoV2 inflammation and its therapeutic targeting with a novel TBK1 inhibitor! kudos to the team @domdenardo @HansbroResearch @Hudson_Research @noxopharm nature.com/articles/s41467-0…
Gantier Lab retweeted
It was great to be a part of this highly collaborative and exciting project!! Congrats to all 🍾🥂
We are delighted to share our work on the importance of TBK1 in SARSCoV2 inflammation and its therapeutic targeting with a novel TBK1 inhibitor! kudos to the team @domdenardo @HansbroResearch @Hudson_Research @noxopharm nature.com/articles/s41467-0…
Gantier Lab retweeted
Thrilled to be part of this fantastic paper out today, highlighting the importance of TBK1 in COVID-19 hyper-inflammation! Great work to all the authors! @CentenaryInst @UTS_Science @NatureComms
We are delighted to share our work on the importance of TBK1 in SARSCoV2 inflammation and its therapeutic targeting with a novel TBK1 inhibitor! kudos to the team @domdenardo @HansbroResearch @Hudson_Research @noxopharm nature.com/articles/s41467-0…
Gantier Lab retweeted
Don't forget to come along to the #RNA Vic minisymposium this Friday afternoon!
Five speakers from across Melbourne including @SciMelb, @MonashBDI, @WEHI_research and @SVIResearch (that's me 😁) covering all your fave RNA topics.
It's gonna be fun! rnavic.com/
Gantier Lab retweeted
Great to read all about the innovative @Hudson_Research work in their annual report, with Noxopharm subsidiary Pharmorage’s collaboration with @GantierLab appearing as the #mRNA technology gathers momentum: issuu.com/hudsoninstitute/do…